Baisong Mei
Chief Medical OfficerDr. Baisong Mei, M.D., Ph.D., is Chief Medical Officer of City Therapeutics, Inc. since joining in March 2025. Dr. Mei was Executive VP & Chief Medical Officer of Editas Medicine, Inc. from July 18, 2022. Dr. Mei joins Editas Medicine from Sanofi, where he served as Senior Global Project Head in Rare Disease and Rare Blood Disorders. Prior to Sanofi, Dr. Mei was the Therapeutic Area Head for Hematology Clinical Development at Biogen. Dr. Mei held leadership positions with increasing responsibilities in drug discovery research and CMC development at Biogen and Bayer. Dr. Mei received a Bachelor of Medicine from Bengbu Medical University, China, a Master of Medicine from Wuhan University School of Medicine, China and a Ph.D. in Biochemistry and Molecular Biology from the University of Toledo and held postdoctoral fellowships at the University of California San Francisco and the University of California Berkeley.
Positions
- Company NameCity Therapeutics, Inc.Stock CodeCTYPositionChief Medical Officer
